Results 21 to 30 of about 9,019,898 (255)

Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study. [PDF]

open access: yes, 2012
Increased mortality among men on antiretroviral therapy (ART) has been documented but remains poorly understood.
Giddy, Janet   +56 more
core   +2 more sources

Antiretroviral agents against human immunodeficiency virus

open access: yesDST, 2022
Introduction: Since its discovery in the 1980s, the human immunodeficiency virus (HIV) has been the target of many studies. Nowadays, estimates show that 36.7 million people are infected with HIV worldwide.
Ingrid Barcelos de Oliveira   +4 more
doaj  

Duration of Highly Active Antiretroviral Therapy Regimens [PDF]

open access: yesClinical Infectious Diseases, 2003
The median duration of highly active antiretroviral therapy (HAART) regimens was reported to be 11.8 months in one US study, but that study included both treatment-experienced and treatment-naive patients. The duration of initial HAART regimens for treatment-naive patients alone has not been reported.
Ray Y, Chen   +9 more
openaire   +2 more sources

Excess mortality and associated factors among people living with HIV initiating highly active antiretroviral therapy in Luzhou, China 2006–2020

open access: yesBMC Infectious Diseases, 2023
Background To estimate crude mortality, excess mortality, and standardized mortality rates (SMR) among people living with HIV (PLHIV) initiating highly active antiretroviral therapy (HAART) in Luzhou, China 2006–2020, and assess associated factors ...
Dandan Niu   +16 more
doaj   +1 more source

Long-term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa. [PDF]

open access: yes, 2011
BACKGROUND: Concerns have been raised that marginalised populations may not achieve adequate compliance to antiretroviral therapy. Our objective was to describe the long-term virological, immunological and mortality outcomes of providing highly active ...
Van de Perre, Philippe   +29 more
core   +2 more sources

Does direct observation of antiretroviral therapy improve outcomes for HIV/AIDS patients compared to non-observed therapy?: A systematic review and meta-analysis of randomized-controlled trials [PDF]

open access: yes, 2009
Includes bibliographical references.Highly active antiretroviral therapy (HAART) has dramatically affected the course of HIV disease, resulting in a significant reduction in AIDS-related morbidity and mortality in both developed and developing ...
Ford, Nathan
core   +1 more source

Update on highly active antiretroviral therapy: progress and strategies [PDF]

open access: yesBiomedicine & Pharmacotherapy, 2000
HIV patients who have detectable viral loads (1,000-5,000 copies/mL) and/or evidence of immunologic dysfunction (CD4+ T-lymphocyte count < 500/mm3) should be treated with a potent combination antiretroviral regimen. Currently, this is to consist of two nucleoside reverse transcriptase inhibitors (NRTIs) with at least one protease inhibitor (PI), or a ...
Clumeck, Nathan, De Wit, Stéphane
openaire   +2 more sources

Highly active antiretroviral therapy: Does it Sound toxic?

open access: yesJournal of Pharmacy and Bioallied Sciences, 2011
Objective : The main objective of the current study is to monitor the auditory status in a group of adults with AIDS, receiving Highly Active Antiretroviral Therapy (HAART) (3TC -lamivudine, D4T - stavudine, and efavirenz) in a hospital outpatient clinic
Katijah Khoza-Shangase
doaj   +1 more source

Variable impact on mortality of AIDS‐Defining events diagnosed during combination antiretroviral therapy: Not All AIDS‐defining conditions are created equal [PDF]

open access: yes, 2009
Background The extent to which mortality differs following individual acquired immunodeficiency syndrome (AIDS)–defining events (ADEs) has not been assessed among patients initiating combination antiretroviral therapy.
Justice, Amy   +902 more
core   +2 more sources

Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy [PDF]

open access: yes, 2005
Background. Very low rates of mother-to-child transmission (MTCT) of human immunodeficiency virus (HIV) are achievable with use of highly active antiretroviral therapy (HAART).
Canet, Y   +214 more
core   +1 more source

Home - About - Disclaimer - Privacy